Shine Lawyers Logo
1800 618 851

Essure Class Action Investigation - Birth Control Complications

Essure is the subject of significant legal debate in the US and more than 1,000 women have contacted the FDA reporting complications associated with the device.

Essure has been available here in Australia since 2010 and Shine has been contacted by a number of Australian women who have reported complications related to the device. These women have reported experiencing extreme abdominal pain, unwanted pregnancies, fatigue and have developed allergies to metals and other substances.

In the United States, the list of complications is longer. With women reporting severe complications including perforation of the uterus or fallopian tubes, haemorrhaging and device migration.

Shine Lawyers is now investigating the potential for a group action for Australian women who’ve been affected by the Essure contraception device.

If you suffered any complications after receiving the Essure contraceptive, you may be entitled to compensation. We encourage you to register your interest with us for news and updates on the class action investigation. We can help evaluate your claim on a no win no fee basis.

Sign up Class Action Investigation

Our offer to you

Shine Lawyers | Service Icon | Shine Lawyers

Obligation-free initial consultation to assess your case confidentially

Shine Lawyers | Service Icon | Shine Lawyers

Claim assessment process where we will explain all of the options available to you

Shine Lawyers | Service Icon | Shine Lawyers

We can come to you - if you can't make it into the office we're more than happy to come to you

Shine Lawyers | Service Image | Shine Lawyers

No Win No Fee arrangement

Common Questions

We understand that since 1999, an estimated 750,000 procedures have taken place around the world. Since then, the device has been the subject of more than 1,000 complaints in the US.Essure has been available in Australia since 2010. While the number of women implanted in Australia is unknown, based on the situation in the US, the numbers could be significant.

The device is still available in Australia. It is currently listed on the Australian Register for Therapeutic goods as Active.

If an Australian Class action or group action were to proceed, it could be argued that the product was unfit for its purpose and that its quality and safety sits below what is expected under Australian Competition and Consumer Law. Furthermore, it may be argued that the manufacturer breached its duty of care to patients in the design, manufacture, marketing and supply of the product.

While litigation can never take away the loss and pain those affected may have experienced, it would seek to recover the compensation those who’ve been harmed need to access the medical treatment they now require.

There may be hundreds of Australian women harmed by this device and who may be entitled to recover damages for what they’ve suffered. It’s important that these women speak up about their experiences.

Anyone implanted with one of these devices and who is suffering should seek independent legal advice as soon as possible.

Essure is the commercial name for a device designed by Bayer for sterilization or permanent birth control. Flexible coils are inserted transvaginally under local or general anaesthesia.

Essure’s micro-inserts are comprised of an expanding coil made of a stainless steel inner coil, a nickel Titanium (nitinol) expanding outer coil and polyethylene (PET) fibres. After placement of the coils in the fallopian tubes, the micro-inserts expand upon release and anchor into the fallopian tubes. The PET fibres cause inflammation in the fallopian tubes, causing scar tissue to form over the coils, thus blocking fertilization.

Enquire Now

If required, we gather more details or documents later in the process.
We're available to talk